Physician profile
Hilton Becker
NPI 1467672139
$514,896.00
in general payments reported to CMS, 2019-2025
18 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $80K · 2021: $80K · 2022: $49K · 2023: $65K · 2024: $64K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $193K · Food and Beverage: $1,549 · Travel and Lodging: $1,314 · Long Term Medical Supply Or Device Loan: $326 · Gift: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $192,891.38 |
| Food and Beverage | $1,548.51 |
| Travel and Lodging | $1,314.47 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Gift | $310.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $512,756.66 | 2019-2025 | Mentor Memorygel Breast Implant, Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $629.19 | 2023-2025 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $304.98 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $204.17 | 2019-2020 | |
| Innovation Technologies INC | $170.15 | 2024 | Irrisept |
| Kerecis Limited | $149.58 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $126.08 | 2020-2022 | |
| Rti Surgical, INC | $123.53 | 2024 | Fortiva Porcine Dermis |
| Baxter Healthcare | $105.84 | 2023 | Tisseel |
| Davol INC. | $100.00 | 2023 | Arista Ah Flexitip |
| Galderma Laboratories, L.P. | $66.20 | 2020-2025 | Dysport |
| Boston Scientific Corporation | $42.47 | 2021 | |
| Tepha INC | $30.33 | 2019 | |
| Vertical Pharmaceuticals, LLC | $28.69 | 2023 | Dsuvia |
| Kci USA, INC. | $15.79 | 2023 | Prevena Restor Bellaform |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $14.48 | 2022 | |
| Baudax Bio INC. | $14.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.64 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilton Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.